| Literature DB >> 33330652 |
Yuchen Ying1, Shaoyi Lin2, Fanqian Kong3, Yuying Li4, Shujun Xu1, Xiaofeng Liang5, Changyi Wang6, Liyuan Han7,8.
Abstract
Background: This study aimed to assess the relationship between ideal cardiovascular health (CVH) metrics and incident ischemic stroke (IS) in hypertensive patients, especially those with hyperhomocysteinemia (HHcy).Entities:
Keywords: hyperhomocysteinemia; hypertensive patients; ideal cardiovascular health metrics; ischemic stroke; prospective study
Year: 2020 PMID: 33330652 PMCID: PMC7719670 DOI: 10.3389/fcvm.2020.590809
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
The HRs (95% CIs) of incident ischemic stroke by Cardiovascular Health Metrics and sex.
|
|
|
| |||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
|
| |||||||
| Cases | 8 | 23 | 47 | 42 | 21 | 7 | |
| Number of participants | 84 | 348 | 647 | 700 | 401 | 147 | |
| M0 | 1 [Reference] | 0.73 | 0.35 | 0.41 | 0.37 | 0.22 | 0.006 |
| M1 | 1 [Reference] | 0.70 | 0.32 | 0.38 | 0.34 | 0.21 | 0.005 |
| M2 | 1 [Reference] | 0.80 | 0.37 | 0.45 | 0.37 | 0.22 | 0.019 |
|
| |||||||
| Cases | 4 | 31 | 52 | 60 | 34 | 11 | |
| Number of participants | 38 | 284 | 598 | 741 | 506 | 168 | |
| M0 | 1 [Reference] | 0.47 | 0.42 | 0.35 | 0.33 | 0.31 | 0.036 |
| M1 | 1 [Reference] | 0.47 | 0.41 | 0.35 | 0.32 | 0.31 | 0.033 |
| M2 | 1 [Reference] | 0.42 | 0.30 | 0.25 | 0.25 | 0.25 | 0.020 |
|
| |||||||
| Cases | 12 | 54 | 99 | 102 | 55 | 18 | |
| Number of participants | 122 | 632 | 1,245 | 1,441 | 907 | 315 | |
| M0 | 1 [Reference] | 0.57 | 0.39 | 0.37 | 0.36 | 0.28 | <0.001 |
| M1 | 1 [Reference] | 0.55 | 0.37 | 0.36 | 0.34 | 0.27 | <0.001 |
| M2 | 1 [Reference] | 0.62 | 0.37 | 0.37 | 0.34 | 0.28 | <0.001 |
BMI, body mass index.
All non-pregnant participants older than 20 years with available cardiovascular health metrics were included.
Not adjusted.
Adjusted for age, sex.
Adjusted for age, sex, education, alcohol consumption, diabetes mellitus, depression, family history of stroke, years of hypertension, antihypertensive medication, low density lipoprotein, systolic blood pressure, diastolic blood pressure, uric acid, triglyceride, total homocysteine and creatinine.
The HRs (95% CIs) of incident ischemic stroke by each cardiovascular health metrics.
|
|
|
|
|
|
|---|---|---|---|---|
| Smoking status | ||||
| Ideal | −0.13 | 0.88 | 0.60–1.29 | 0.523 |
| Intermediate | 0.08 | 1.08 | 0.69–1.67 | 0.727 |
| Poor | Reference | |||
| physical activity | ||||
| Ideal | −0.12 | 0.88 | 0.67–1.16 | 0.371 |
| Intermediate | 0.08 | 1.08 | 0.69–1.68 | 0.733 |
| Poor | Reference | |||
| BMI | ||||
| Ideal | −0.17 | 0.84 | 0.58–1.22 | 0.375 |
| Intermediate | −0.16 | 0.85 | 0.59–1.21 | 0.380 |
| Poor | Reference | |||
| Healthy diet score | ||||
| Ideal | −0.63 | 0.53 | 0.33–0.86 | 0.010 |
| Intermediate | −0.43 | 0.65 | 0.42–0.99 | 0.047 |
| Poor | Reference | |||
| Total serum cholesterol | ||||
| Ideal | 0.05 | 1.05 | 0.62–1.76 | 0.861 |
| Intermediate | −0.06 | 0.94 | 0.63–1.41 | 0.771 |
| Poor | Reference | |||
| Fasting blood glucose | ||||
| Ideal | −1.12 | 0.32 | 0.17–0.62 | <0.001 |
| Intermediate | −0.94 | 0.39 | 0.23–0.66 | <0.001 |
| Poor | Reference | |||
BMI, body mass index.
Adjusted for age, sex, education, alcohol consumption, diabetes mellitus, depression, family history of stroke, years of hypertension, antihypertensive medication, low density lipoprotein, systolic blood pressure, diastolic blood pressure, uric acid, triglyceride, total homocysteine and creatinine.
Figure 1Adjusted hazard ratios and population attributable fractions of ischemic stroke events in relation to number of ideal cardiovascular health metrics among participants with hyperhomocysteinemia compared with normal homocysteine. Pys, Person years; Hcy, homocysteine; CVH, cardiovascular health metrics.
The HRs (95% CIs) of incident ischemic stroke by Cardiovascular Health Metrics and age, hypertension duration, controlled blood pressure, and homocysteine.
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||
| Age, years | 0.506 | |||||||
| <60 | 1.00 | 0.82 | 0.36 | 0.46 | 0.39 | 0.14 | 0.020 | |
| ≥60 | 1.00 | 0.52 | 0.33 | 0.31 | 0.31 | 0.35 | 0.025 | |
| Hypertension duration, years | 0.578 | |||||||
| <5 | 1.00 | 1.52 | 0.83 | 0.56 | 0.77 | 0.32 | 0.009 | |
| ≥5 | 1.00 | 0.32 | 0.18 | 0.20 | 0.15 | 0.17 | 0.006 | |
| Controlled blood pressure, mmHg | 0.508 | |||||||
| SBP < 130 or DBP < 80 | 1.00 | 0.99 | 0.51 | 0.58 | 0.60 | 0.41 | 0.108 | |
| SBP≥130 or DBP≥80 | 1.00 | 0.32 | 0.21 | 0.18 | 0.16 | 0.21 | 0.007 | |
| Homocysteine, μmol/L | 0.412 | |||||||
| <15 | 1.00 | 0.21 | 0.11 | 0.12 | 0.11 | 0.13 | 0.025 | |
| ≥15 | 1.00 | 1.21 | 0.87 | 0.65 | 0.61 | 0.30 | 0.012 | |
SBP, systolic blood pressure; DBP, diastolic blood pressure.
All non-pregnant parti5cipants older than 20 years with available cardiovascular health metrics were included.
Trends were analyzed by logistic regression model with adjustment for age and sex.
Adjusted for age, sex, education, alcohol consumption, diabetes mellitus, depression, family history of stroke, years of hypertension, antihypertensive medication, low density lipoprotein, systolic blood pressure, diastolic blood pressure, uric acid, triglyceride, total homocysteine and creatinne.